Table 7

VRK2 as independent marker in univariate and multivariate survival analysis in high-grade astrocytomas
Univariate analysis Multivariate analysis
Parameter HR (95% C.I.) Pvalue HR (95% C.I.) Pvalue
VRK2 expression 1.80 (1.07 – 3.02) 0.025 2.10 (1.24 – 3.58) 0.006
Age (<60 vs. ≥ 60) 1.94 (1.15 – 3.26) 0.011 1.80 (1.06 – 3.05) 0.031
Treatment (Chemo + RT vs. RT alone vs. no treatment) 1.96 (1.22 – 3.15) 0.003 2.01 (1.22 – 3.30) 0.006

HR: hazard ratio. RT: Radiotherapy. Chemo: Chemotherapy.

Rodríguez-Hernández et al.

Rodríguez-Hernández et al. BMC Clinical Pathology 2013 13:23   doi:10.1186/1472-6890-13-23

Open Data